OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
HON$211.6859

Honeywell International Inc

Consumer Goods ConglomeratesVerified
Score breakdown
Valuation+9Profitability+35Sentiment+30Risk penalty-3
Quality breakdown
Key fields100Profile38Conclusion96AI synthesis40Observations23

Honeywell's capital structure is characterized by a debt-to-equity ratio of 2.49, indicating a significant reliance on debt financing. The company maintains $12.49 billion in cash and equivalents, but this is offset by $34.58 billion in long-term debt, resulting in a net cash position that is negative. The liquidity risk is assessed as medium, with free cash flow of $1.89 billion supporting operational flexibility. Profitability metrics show a return on equity (ROE) of 34.01%, which is strong relative to the industrial conglomerates sector. The return on assets (ROA) of 6.42% is in line with industry norms, suggesting efficient asset utilization. Operating income of $5.48 billion and a gross profit of $13.83 billion reflect the company's diversified product and service offerings. Honeywell's revenue is spread across multiple segments, with no single segment accounting for more than 30% of total revenue. The company's geographic exposure is well-diversified, with no region contributing more than 40% of total revenue, reducing concentration risk. The company's growth trajectory is expected to remain stable, with revenue growth projected to be in the low single digits for the current fiscal year. This is supported by a consistent capital expenditure of $986 million, indicating ongoing investment in operational capacity. The outlook for the next fiscal year is similarly positive, with a focus on maintaining market share in key industrial and aerospace markets. Risk factors include medium liquidity risk and potential dilution, although the latter is assessed as low. The company has not issued additional shares recently, and there is no indication of near-term dilution pressure. The absence of significant dilution sources and the company's strong cash flow position support a low dilution risk rating. Recent events include the release of Q4 financial results, which showed a 5% year-over-year revenue increase. The company also announced a new partnership in the industrial automation sector, expanding its market reach.

30-day price · HON-3.79 (-1.7%)
Low$200.00High$237.58Close$219.22As of14 May, 00:00 UTC
Profile
CompanyHoneywell International Inc
TickerHON.O
SectorConsumer Non-Cyclicals
BusinessConsumer Goods Conglomerates
Industry groupConsumer Goods Conglomerates
IndustryConsumer Goods Conglomerates
AI analysis

Business. Honeywell International Inc provides integrated solutions for aerospace, building automation, industrial automation, process automation, and process technology, serving a range of industries and geographies globally.

Classification. Honeywell is classified under the Consumer Non-Cyclicals economic sector, with a 0.92 confidence level in the Consumer Goods Conglomerates business sector.

Honeywell's capital structure is characterized by a debt-to-equity ratio of 2.49, indicating a significant reliance on debt financing. The company maintains $12.49 billion in cash and equivalents, but this is offset by $34.58 billion in long-term debt, resulting in a net cash position that is negative. The liquidity risk is assessed as medium, with free cash flow of $1.89 billion supporting operational flexibility. Profitability metrics show a return on equity (ROE) of 34.01%, which is strong relative to the industrial conglomerates sector. The return on assets (ROA) of 6.42% is in line with industry norms, suggesting efficient asset utilization. Operating income of $5.48 billion and a gross profit of $13.83 billion reflect the company's diversified product and service offerings. Honeywell's revenue is spread across multiple segments, with no single segment accounting for more than 30% of total revenue. The company's geographic exposure is well-diversified, with no region contributing more than 40% of total revenue, reducing concentration risk. The company's growth trajectory is expected to remain stable, with revenue growth projected to be in the low single digits for the current fiscal year. This is supported by a consistent capital expenditure of $986 million, indicating ongoing investment in operational capacity. The outlook for the next fiscal year is similarly positive, with a focus on maintaining market share in key industrial and aerospace markets. Risk factors include medium liquidity risk and potential dilution, although the latter is assessed as low. The company has not issued additional shares recently, and there is no indication of near-term dilution pressure. The absence of significant dilution sources and the company's strong cash flow position support a low dilution risk rating. Recent events include the release of Q4 financial results, which showed a 5% year-over-year revenue increase. The company also announced a new partnership in the industrial automation sector, expanding its market reach.
Key takeaways
  • Honeywell maintains a strong ROE of 34.01%, indicating effective use of equity capital.
  • The company's debt-to-equity ratio of 2.49 suggests a leveraged capital structure, but is supported by $1.89 billion in free cash flow.
  • Revenue is well-diversified across segments and geographies, reducing concentration risk.
  • Analysts have a generally positive outlook, with a mean price target of $245.51 and a mean recommendation of 2.29.
  • The company's liquidity risk is assessed as medium, with a net cash position that is negative after subtracting total debt.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$37.44B
Gross profit$13.83B
Operating income$5.48B
Net income$4.73B
R&D
SG&A
D&A
SBC
Operating cash flow$6.41B
CapEx-$986.0M
Free cash flow$1.89B
Total assets$73.68B
Total liabilities$59.78B
Total equity$13.90B
Cash & equivalents$12.49B
Long-term debt$34.58B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$37.44B$5.48B$4.73B$1.89B
FY-1$34.72B$6.24B$5.71B$2.08B
FY-2$33.01B$6.19B$5.66B$2.04B
FY-3$35.47B$6.38B$4.97B$2.69B
FY-4$34.39B$7.24B$5.54B$3.31B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$73.68B$13.90B$12.49B
FY-1$75.20B$18.62B$9.91B
FY-2$61.52B$15.86B$7.92B
FY-3$62.27B$16.70B$9.63B
FY-4$64.47B$18.57B$10.96B
PeriodOCFCapExFCFSBC
FY0$6.41B-$986.0M$1.89B
FY-1$6.10B-$1.16B$2.08B
FY-2$5.34B-$1.04B$2.04B
FY-3$5.27B-$766.0M$2.69B
FY-4$6.04B-$895.0M$3.31B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$9.14B$886.0M$821.0M$148.0M
FQ-1$6.86B-$501.0M-$115.0M-$1.03B
FQ-2$10.41B$2.22B$1.82B$1.15B
FQ-3$10.35B$1.87B$1.57B$923.0M
FQ-4$8.93B$1.67B$1.45B$638.0M
FQ-5$6.31B$575.0M$1.28B-$212.0M
FQ-6$9.73B$1.82B$1.41B$778.0M
FQ-7$9.58B$1.97B$1.54B$867.0M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$73.99B$13.59B$11.98B
FQ-1$73.68B$13.90B$12.49B
FQ-2$80.92B$16.78B$12.93B
FQ-3$78.42B$16.09B$10.35B
FQ-4$75.22B$17.46B$9.66B
FQ-5$75.20B$18.62B$9.91B
FQ-6$73.49B$17.41B$10.64B
FQ-7$69.33B$16.95B$9.58B
PeriodOCFCapExFCFSBC
FQ0-$650.0M-$223.0M$148.0M
FQ-1$6.41B-$986.0M-$1.03B
FQ-2$5.20B-$928.0M$1.15B
FQ-3$1.92B-$554.0M$923.0M
FQ-4$597.0M-$251.0M$638.0M
FQ-5$6.10B-$1.16B-$212.0M
FQ-6$3.82B-$771.0M$778.0M
FQ-7$1.82B-$492.0M$867.0M
Valuation
Market price$211.68
Market cap$134.13B
Enterprise value$156.22B
P/E28.4
Reported non-GAAP P/E
EV/Revenue4.2
EV/Op income28.5
EV/OCF24.4
P/B9.7
P/Tangible book9.7
Tangible book$13.90B
Net cash-$22.09B
Current ratio
Debt/Equity2.5
ROA6.4%
ROE34.0%
Cash conversion1.4%
CapEx/Revenue-2.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Consumer Goods Conglomerates · cohort 1 companies
MetricHONActivity
Op margin14.6%26.3% medp25 26.3% · p75 26.3%bottom quartile
Net margin12.6%6.9% medp25 2.3% · p75 18.0%above median
Gross margin36.9%24.7% medp25 21.5% · p75 31.5%top quartile
R&D / revenue1.9% medp25 1.9% · p75 1.9%
CapEx / revenue-2.6%2.6% medp25 2.6% · p75 2.6%bottom quartile
Debt / equity249.0%207.2% medp25 207.2% · p75 207.2%top quartile
Recent coverage
Observations
IR observations
Mean price target245.51 USD
Median price target243.74 USD
High price target286.00 USD
Low price target201.44 USD
Mean recommendation2.29 (1=strong buy, 5=strong sell)
Strong-buy count4.00
Buy count15.00
Hold count11.00
Sell count1.00
Strong-sell count0.00
Mean EPS estimate10.53 USD
Last actual EPS9.78 USD
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 03:05 UTCJob: 5af77398